Post-Hoc Live podcast

Live from Boston: Investor math versus industrial priority

0:00
45:10
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Should investors embrace China’s fast-moving, fast-growing biotech sector, or should there be barriers to protect and preserve an industry that the US has dominated for decades? Ginkgo Bioworks CEO Jason Kelly, RA Capital Management's Peter Kolchinsky, and MIT professor Fiona Murray debate all sides of the flashpoint issue.Live from Endpoints’ China Biotech Debate: Boston on August 6, 2026.


Flere episoder fra "Post-Hoc Live"